Although the European regulator assures that the AstraZeneca vaccine is “safe and effective”, Denmark emphasizes that it will still wait to repeat the vaccinations with this preparation.
«Our decision to suspend vaccination with AstraZeneca Covid-19 vaccine until the 12th week (March 22-28) remains in force“, Said the director of the Danish Health Service (Sundhedsstyrelsen) Soren Brostrem, in an announcement issued late on Thursday night (18/3).
“In the coming days, Sundhedsstyrelsen and the Danish Medicines Agency will evaluate the impact of the EMA (European Medicines Agency) opinion on the vaccine against Covid-19 of AstraZeneca for the vaccination program of Denmark “, added as broadcast by the Athenian News Agency.

Last week, Denmark was the first country to completely suspend the use of the AstraZeneca vaccine, followed by about fifteen countries, mostly Europeans.
According to Danish authorities, who are expected to answer questions from reporters this afternoon, even if the European regulator confirms the benefits of the vaccine, “it does not rule out a link between some known, rare but serious cases of blood clots and vaccination with her vaccine AstraZeneca».
Denmark is currently investigating ten cases, including one death in which blood clots or blood clot symptoms appeared after at least 140,000 people were vaccinated with a single dose of the Swedish-British pharmaceutical group vaccine.
All Nordic countries, except Finland, have suspended use of the vaccine due to concerns related to blood clots. Sweden and Norway have said they will wait before resuming vaccinations, while Iceland has not yet announced its position.

Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.